News

Findings from a recent study confirmed the prognostic value of immunoglobulin heavy chain mutational status at diagnosis for overall survival and time to first treatment in patients with chronic lymphocytic leukemia.

A real-world analysis of patient-reported outcomes in CLL/SLL revealed that quality-of-life scores remained stable over the first 12 months of treatment.

The number of percutaneous and open procedures as well as reimbursement per procedure have progressively expanded from 2000 to 2019, according to a recent study.

Complete cytoreductive surgery with minimally invasive surgery may be a safe and effective choice for interval debunking surgery after neo-adjuvant chemotherapy among patients with advanced ovarian cancer.

Findings from a recent study revealed the efficacy of the antimesothelin treatment strategy in ovarian cancer and provided preliminary data for the expansion of additional clinical trials.

The assessment of circulating tumor cells in peripheral blood outperformed quantification of bone marrow plasma cells and the discovery of ≥ 0.01% CTCs could be a new risk factor in novel staging systems for patients with transplant-eligible...

Study findings reveal that among a large cohort of patients treated primarily in the US community setting, one in four patients received cytarabine or autologous stem-cell transplant consolidation, indicating the need to develop treatments...

Findings from a recent study suggest that skilled nursing facilities responded to the patient driven payment model with changes in individual occupational therapy and physical therapy utilization, but no changes in rates of discharge to the...

Researchers provided evidence-based recommendations updating the 2020 ASCO and Ontario Health (Cancer Care Ontario) guideline on systemic therapy for patients with stage IV non–small-cell lung cancer without driver alterations.

Patients with newly diagnosed multiple myeloma treated with combination regimen of bortezomib, lenalidomide, and dexamethasone induction followed by early autologous stem cell transplantation (ASCT) may not have a greater occurrence of...